Press "Enter" to skip to content

New patent for Puma Biotech drug NERLYNX

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for NERLYNX
Annual Drug Patent Expirations for NERLYNX

Nerlynx is a drug marketed by Puma Biotech and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

This drug has one hundred and forty-eight patent family members in thirty-one countries.

The generic ingredient in NERLYNX is neratinib maleate. One supplier is listed for this compound. Additional details are available on the neratinib maleate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions